Impact on Male Rat Reproductive Tract Development Vickie S

Total Page:16

File Type:pdf, Size:1020Kb

Impact on Male Rat Reproductive Tract Development Vickie S international journal of andrology ISSN 0105-6263 REVIEW ARTICLE Diverse mechanisms of anti-androgen action: impact on male rat reproductive tract development Vickie S. Wilson,* Chad R. Blystone,* Andrew K. Hotchkiss,* Cynthia V. Rider* and L. Earl Gray Jr* *US Environmental Protection Agency, Office of Research and Development, National Health and Environmental Effects Laboratory, Reproductive Toxicology Division, North Carolina, and North Carolina State University, Raleigh, NC, USA Summary Keywords: Scientists have identified environmental chemicals that display anti-androgenic androgen receptor, anti-androgen, linuron, activity via multiple mechanisms of action. Early studies focused on pesticides phthalate, prochloraz, reproductive acting as androgen receptor (AR) antagonists but it soon became apparent that development, vinclozolin was not the only endocrine mode by which compounds affected the androgen signalling pathway. Classes of chemicals currently known to interfere with the Correspondence: Vickie S. Wilson, US Environmental Protection androgen signalling pathway include dicarboximide fungicides (e.g. vinclozolin), Agency, ORD, National Health and organochlorine-based insecticides (e.g. p,p¢-DDT and -DDE), conazole fungi- Environmental Effects Laboratory, cides (e.g. prochloraz), plasticizers (phthalates) and urea-based herbicides (linu- Reproductive Toxicology Division, MD-72, ron). Phthalate esters (PEs) and vinclozolin appear to act primarily via a single 2525 E. Highway 54, Research Triangle Park, mechanism of action, while others such as linuron and prochloraz, appear to NC 27711, USA. display dual mechanisms of action. Exposure to PEs decreases mRNA expres- E-mail: [email protected] sion of key steroidogenic enzymes and also the peptide hormone insulin-like Received 30 October 2007; revised 13 peptide 3 (insl3) from the foetal Leydig cells. Hence, both androgen- and inls3- December 2007; accepted 18 December 2007 dependent tissues are affected. Vinclozolin and procymidone act solely through binding to the AR as antagonists thus blocking the action of androgen at the doi:10.1111/j.1365-2605.2007.00861.x cellular level but do not affect foetal testosterone synthesis or insl3 gene expres- sion. The compounds linuron and prochloraz are AR antagonists but also inhi- bit foetal testosterone synthesis, although unlike the PEs, mRNA expression of steroidogenic enzymes and insl3 are not affected. All the above chemicals dis- rupt androgen signalling in the foetal male rat and produce some malforma- tions in common, but the precise profiles of effects in the offspring are pathognomonic for each mode of action. For example, the ‘phthalate syn- drome’ vs. the ‘vinclozolin syndrome’ each displays a profile of effects which is clearly different. In summary, as more and more molecular studies with anti- androgenic compounds are conducted, the number of mechanisms by which compounds can affect the androgen signalling pathway is likely to increase. Furthermore, the effects of mixtures of these compounds are just beginning to be explored. pathologies (Jegou et al., 2001). As only a small percent- Introduction age of these lesions can be linked directly to known Concern has risen over the apparent increase in male genetic defects, developmental exposure to man-made reproductive health problems and the potential role of chemicals has been implicated in the increases in these endocrine disrupting chemicals (EDCs) in the aetiology reproductive malformations. of these conditions (Skakkebaek, 2002a). Declining sperm Compounds that disrupt endocrine signalling pathways counts and increased incidences of hypospadias, cryptor- can act via several mechanisms including binding to hor- chidism and testis cancer have all been reported. The mone receptors, modifying the production or metabolism worldwide doubling in the rate of testicular cancer over of endogenous hormones, or modifying the number of the last 40 years is one of the more robust of these hormone receptors. For example, androgen agonists bind Journal compilation ª 2008 Blackwell Publishing Ltd • International Journal of Andrology 31, 178–187 178 No claim to original US government works V. S. Wilson et al. Diverse mechanisms of anti-androgen action to androgen receptors and mimic natural hormones signalling pathway through slightly different mechanisms, which may initiate a cascade of events resulting in inap- there are both similarities and differences in androgen- propriate expression of hormone-dependent genes. Con- dependent tissue effects and the profile of malformations versely, androgen receptor (AR) antagonists compete with which are produced. In the course of this summary, endogenous androgen for the receptor and prevent down- mechanism-based groups of anti-androgens was discussed stream activation of androgen-dependent gene expression. with focus on the pathognomic effects of each class of While early research focused on the ability of environ- anti-androgen. The terms ‘low’ dose and ‘high’ dose will mental compounds to impact androgen binding to its generally be used in the discussion. The specific doses receptor, it is now clear that it is not the only mechanism which fit each of these categories are dependent on the through which compounds can interfere with the andro- potency and mechanism of action of each compound dis- gen signalling pathway. In addition, some compounds cussed and will clearly be different for each individual appear to act through more than one mechanism, each of compound. Information on the actual dose can be found which having the potential impact on the androgen sig- in the reference literature. Generally, low dose refers to nalling pathway at different points. a dose near or just above the no observed adverse effect Mammalian gonadal development and sex differentia- level for the individual compound. Additionally, we cover tion occur during a relatively narrow time window. The the differential effects between two strains of rats exposed production of testosterone and other hormones by the to the same anti-androgen. Lastly, we discuss conclusions foetal testis during this period are critical factors for and future directions for this work including the study of the proper development of the male reproductive tract complex mixtures of anti-androgens with diverse mecha- (Schardein, 1993). In utero exposure to chemicals that nisms of action. disrupt androgen signalling during this window can result in alterations that may include reduced anogenital dis- Androgen receptor antagonists tance (AGD), increase in female-like nipple retention, epi- didymal agenesis, reduction in sex accessory gland Several environmental chemicals adversely affect male weights, cryptorchidism, hypospadias and reduced fertil- development by interfering with androgen receptor signal- ity. Generally, in utero exposure to anti-androgenic chem- ling during the critical periods (in utero or peri-pubertal) icals affects male offspring, while having little effect on of sex differentiation and maturation. Depending on the female offspring. Androgenic chemicals, conversely, have timing of developmental exposure, these anti-androgens been shown to induce malformations in exposed female affect androgen-sensitive organs and processes within the offspring and have little to no effect on males. male rat leading to altered neuroendocrine development The suite of effects following in utero exposure to and behaviour, reduced reproductive organ weights and endocrine disruptors can be indicative of the mechanism malformations of external genitalia and reproductive of action of the chemical exposure. In addition to the organs. Several anti-androgenic chemicals have been iden- effects mentioned above from androgenic and anti-andro- tified as androgen receptor (AR) antagonists including: genic exposure, environmental oestrogens have been the fungicides vinclozolin (Gray et al., 1994; Kelce & Wil- found to cause infertility or shorten the reproductive life- son, 1997), procymidone (Hosokawa et al., 1993; Ostby span of in utero exposed females. Compounds such as et al., 1999), prochloraz (Vinggaard et al., 2002; Noriega 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) elicit et al., 2005), the DDT metabolite p,p¢-DDE (Kelce et al., effects in the female reproductive tract including malfor- 1995), the herbicide linuron (Gray et al., 1999a; Lam- mations of the external genitalia, reduced ovarian weight bright et al., 2000) and polybrominated diphenyl ethers and can also decrease their reproductive lifespan. In fact, flame retardants (Stoker et al., 2005). a relatively low single oral dose of 1–2 lg ⁄ kg 2,3,7,8- In utero exposure to chemicals that disrupt AR signal- TCDD given to the dam during gestation can produce ling leads to a host of typical effects in male rat offspring. frank reproductive malformations in both male and External biomarkers of prenatal androgen disruption female offspring. Lastly, foetal germ cell toxicants, such as include the anogenital distance (AGD) and the juvenile busulfan, can cause infertility in females, reduce sperm nipple ⁄ areolae number. The AGD is defined as the dis- production in males and elicit histological lesions in both tance between the genital papilla and the anus; male ovaries and testes without affecting gross morphology of rodents have AGDs that are approximately twice the the reproductive tract in either sex. length as those of females (Vandenbergh & Huggett, The focus of this selective review was to summarize 1995; Gray et al., 1999a,b). Areolae
Recommended publications
  • COMBINED LIST of Particularly Hazardous Substances
    COMBINED LIST of Particularly Hazardous Substances revised 2/4/2021 IARC list 1 are Carcinogenic to humans list compiled by Hector Acuna, UCSB IARC list Group 2A Probably carcinogenic to humans IARC list Group 2B Possibly carcinogenic to humans If any of the chemicals listed below are used in your research then complete a Standard Operating Procedure (SOP) for the product as described in the Chemical Hygiene Plan. Prop 65 known to cause cancer or reproductive toxicity Material(s) not on the list does not preclude one from completing an SOP. Other extremely toxic chemicals KNOWN Carcinogens from National Toxicology Program (NTP) or other high hazards will require the development of an SOP. Red= added in 2020 or status change Reasonably Anticipated NTP EPA Haz list COMBINED LIST of Particularly Hazardous Substances CAS Source from where the material is listed. 6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10- hexachloro-1,5,5a,6,9,9a-hexahydro-, 3-oxide Acutely Toxic Methanimidamide, N,N-dimethyl-N'-[2-methyl-4-[[(methylamino)carbonyl]oxy]phenyl]- Acutely Toxic 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (Methyl-CCNU) Prop 65 KNOWN Carcinogens NTP 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) IARC list Group 2A Reasonably Anticipated NTP 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) (Lomustine) Prop 65 1-(o-Chlorophenyl)thiourea Acutely Toxic 1,1,1,2-Tetrachloroethane IARC list Group 2B 1,1,2,2-Tetrachloroethane Prop 65 IARC list Group 2B 1,1-Dichloro-2,2-bis(p -chloropheny)ethylene (DDE) Prop 65 1,1-Dichloroethane
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,394,315 B2 Aicher Et Al
    USOO93943 15B2 (12) United States Patent (10) Patent No.: US 9,394,315 B2 Aicher et al. (45) Date of Patent: Jul.19, 2016 (54) TETRAHYDROI18NAPHTHYRIDINE 6,605,634 B2 8, 2003 Zablocki et al. SULFONAMIDE AND RELATED 6,638,960 B2 10/2003 Assmann et al. 6,683,091 B2 1/2004 Asberomet al. COMPOUNDS FOR USEAS AGONSTS OF 6,828,344 B1 12/2004 Seehra et al. RORY AND THE TREATMENT OF DISEASE 7,084, 176 B2 8, 2006 Morie et al. 7,138.401 B2 11/2006 Kasibhatla et al. (71) Applicant: Lycera Corporation, Ann Arbor, MI 7,329,675 B2 2/2008 Cox et al. 7,420,059 B2 9, 2008 O'Connor et al. (US) 7,482.342 B2 1/2009 D’Orchymont et al. 7,569,571 B2 8/2009 Dong et al. (72) Inventors: Thomas D. Aicher, Ann Arbor, MI (US); 7,696,200 B2 4/2010 Ackermann et al. Peter L. Toogood, Ann Arbor, MI (US); 7,713.996 B2 5/2010 Ackermann et al. Xiao Hu, Northville, MI (US) 7,741,495 B2 6, 2010 Liou et al. 7,799,933 B2 9/2010 Ceccarelli et al. (73) Assignee: Lycera Corporation, Ann Arbor, MI 2006,0004000 A1 1/2006 D'Orchymont et al. 2006/010O230 A1 5, 2006 Bischoff et al. (US) 2007/0010537 A1 1/2007 Hamamura et al. 2007/OO 10670 A1 1/2007 Hirata et al. (*) Notice: Subject to any disclaimer, the term of this 2007/0049556 A1 3/2007 Zhang et al. patent is extended or adjusted under 35 2007/0060567 A1 3/2007 Ackermann et al.
    [Show full text]
  • Detection of Estrogen Receptor Endocrine Disruptor Potency of Commonly Used Organochlorine Pesticides Using the LUMI-CELL ER Bioassay
    DEVELOPMENTAL AND REPRODUCTIVE TOXICITY Detection of Estrogen Receptor Endocrine Disruptor Potency of Commonly Used Organochlorine Pesticides Using The LUMI-CELL ER Bioassay John D. Gordon1, Andrew C: Chu1, Michael D. Chu2, Michael S. Denison3, George C. Clark1 1Xenobiotic Detection Systems, Inc., 1601 E. Geer St., Suite S, Durham, NC 27704, USA 2Alta Analytical Perspectives, 2714 Exchange Drive, Wilmington, NC 28405, USA 3Dept. of Environmental Toxicology, Meyer Hall, Univ. of California, Davis; Davis, CA 95616 USA Introduction Organochlorine pesticides are found in many ecosystems worldwide as result of agricultural and industrial activities and exist as complex mixtures. The use of these organochlorine pesticides has resulted in the contamination of lakes and streams, and eventually the animal and human food chain. Many of these pesticides, such as pp ’-DDT, pp ’-DDE, Kepone, Vinclozolin, and Methoxychlor (a substitute for the banned DDT), have been described as putative estrogenic endocrine disruptors, and act by mimicking endogenous estrogen 1-3 . Estrogenic compounds can have a significant detrimental effect on the endocrine and reproductive systems of both human and other animal populations 4 . Previous studies have shown a strong association between several EDCs (17p-Estradiol, DES, Zeralanol, Zeralenone, Coumestrol, Genistein, Biochanin A, Diadzein, Naringenin, Tamoxifin) and estrogenic activity via uterotropic assay, cell height, gland number, increased lactoferrin, and a transcriptional activity assay using BG1Luc4E2 cells4 . Some other examples of the effects of these EDCs are: decreased reproductive success and feminization of males in several wildlife species; increased hypospadias along with reductions in sperm counts in men; increase in the incidence of human breast and prostate cancers; and endometriosis 3-5 .
    [Show full text]
  • High-Throughput H295R Steroidogenesis Assay: Utility As an Alternative and a Statistical Approach to Characterize Effects on Steroidogenesis Derik E
    High-throughput H295R steroidogenesis assay: utility as an alternative and a statistical approach to characterize effects on steroidogenesis Derik E. Haggard ORISE Postdoctoral Fellow National Center for Computational Toxicology Computational Toxicology Communities of Practice Dec. 14th, 2017 The views expressed in this presentation are those of the author and do not necessarily reflect the views or policies of the U.S. EPA Outline • Background • Objectives • Assay Background • Methods and Results 1. Evaluation of the HT-H295R assay 2. Development of a quantitative prioritization metric for the HT-H295R assay data • Summary and Conclusions 2 Steroid Hormone Biosynthesis & Metabolism • Proper steroidogenesis is essential: • In utero for fetal development • In adults for reproductive function • Disruption can result in congenital adrenal hyperplasia, sterility, prenatal virilization, salt wasting, etc. • >90% of steroidogenesis occurs in the gonads • Leydig cells (males) or follicular cells (females) • Adrenal gland (corticosteroids) 3 https://www.pharmacorama.com/en/Sections/Androgen_steroid_hormones.php US EPA Endocrine Disruptor Screening Program (EDSP) • EDSP mandated to screen chemicals for endocrine activity (estrogen, androgen, thyroid) • Initial tiered screen relied on low-throughput assays • Modernization of EDSP (EDSP21) to use high-throughput and computational methods • Prioritize the universe of EDSP chemicals for endocrine bioactivity • Altering hormone levels via disruption of biosynthesis or metabolism can also contribute
    [Show full text]
  • WO 2012/148799 Al 1 November 2012 (01.11.2012) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/148799 Al 1 November 2012 (01.11.2012) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 9/107 (2006.01) A61K 9/00 (2006.01) kind of national protection available): AE, AG, AL, AM, A 61 47/10 (2006.0V) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, PCT/US2012/034361 HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (22) International Filing Date: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 20 April 2012 (20.04.2012) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/480,259 28 April 201 1 (28.04.201 1) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (71) Applicant (for all designated States except US): BOARD UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, OF REGENTS, THE UNIVERSITY OF TEXAS SYS¬ TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, TEM [US/US]; 201 West 7th St., Austin, TX 78701 (US).
    [Show full text]
  • Supplemental File 11
    Supplemental File 11 Supplemental Table 11. OECD Reference Chemical Performance in HT H295R versus OECD inter-laboratory results and literature-reported results. Chemical identifiers (chemical name and casn) are provided for the 25 reference chemicals that overlapped between high-throughput (HT) H295R screening and the OECD inter-laboratory validation study (Hecker et al., 2011). Trilostane, glyphosate, and human chorionic gonadotrophin were not screened in the HT H295R assay. The adjusted maxmMd value, quadrants of the steroid synthesis pathway affected (progestagens (P), glucocorticoids (G), androgens (A), and/or estrogens (E)), and the number of steroid hormones affected using the ANOVA-based logic described in the main text are also provided. The OECD inter-laboratory results for estradiol (E2) and testosterone (T) are summarized along with a brief overview of additional information from the reported literature for activity in the H295R assay (if other in vitro assay data are referenced, the assay type is provided). Only 2 of the 25 chemicals with overlapping data were reported as negative for effects on both E2 and T: ethylene dimethanesulfonate and benomyl. NA indicates that no concentration-response screening data were available (only single concentration screening available). # Chemical identifiers Results from HT H295R assay OECD Inter-laboratory and literature-reported Chemical name casn Adjusted maxmMd Quadrants # Steroid results of steroid hormones biosynthesis affected pathway affected 1 Mifepristone 84371-65-3 27 P 2 Used pharmacologically as an abortifacient with antiprogestagen, antiglucocorticoid, and antiandrogen properties. Moderate induction of E2 (2 to 4-fold induction) and T (equivocal) synthesis (Hecker, et al., 2011). Strong modulation of glucocorticoid pathway in H295R cells as a GR antagonist (Asser et al., 2014).
    [Show full text]
  • Hormonal Side Effects in Patients Using Levetiracetam
    Reproductive endocrine side effects of antiepileptic drugs Student Thesis Student: Marte Wendel Gustavsen Class V-03 University of Oslo, Norway Supervisor: Professor Erik Taubøll Department of Neurology, Rikshospitalet University Hospital, Oslo, Norway Contents Contents ...................................................................................................................................... 2 Acknowledgements .................................................................................................................... 3 Abstract ...................................................................................................................................... 4 Introduction ................................................................................................................................ 5 Reproductive endocrine effects of epilepsy ............................................................................... 5 Reproductive hormones can affect epilepsy ............................................................................... 7 Reproductive hormones can influence on AEDs ....................................................................... 9 Reproductive endocrine effects of AEDs ................................................................................... 9 Reproductive endocrine effects of valproate ........................................................................ 11 Women ............................................................................................................................
    [Show full text]
  • Prenatal Testosterone Supplementation Alters Puberty Onset, Aggressive Behavior, and Partner Preference in Adult Male Rats
    J Physiol Sci (2012) 62:123–131 DOI 10.1007/s12576-011-0190-7 ORIGINAL PAPER Prenatal testosterone supplementation alters puberty onset, aggressive behavior, and partner preference in adult male rats Cynthia Dela Cruz • Oduvaldo C. M. Pereira Received: 26 October 2011 / Accepted: 19 December 2011 / Published online: 11 January 2012 Ó The Physiological Society of Japan and Springer 2012 Abstract The objective of this study was to investigate because pregnant women exposed to hyperandrogenemia whether prenatal exposure to testosterone (T) could change and then potentially exposing their unborn children to ele- the body weight (BW), anogenital distance (AGD), ano- vated androgen levels in the uterus can undergo alteration of genital distance index (AGDI), puberty onset, social normal levels of T during the sexual differentiation period, behavior, fertility, sexual behavior, sexual preference, and T and, as a consequence, affect the reproductive and behavior level of male rats in adulthood. To test this hypothesis, patterns of their children in adulthood. pregnant rats received either 1 mg/animal of T propionate diluted in 0.1 ml peanut oil or 0.1 ml peanut oil, as control, Keywords Aggressive behavior Á Male rats Á on the 17th, 18th and 19th gestational days. No alterations in Prenatal testosterone Á Puberty onset Á Sexual behavior Á BW, AGD, AGDI, fertility, and sexual behavior were Sexual differentiation observed (p [ 0.05). Delayed onset of puberty (p \ 0.0001), increased aggressive behavior (p [ 0.05), altered pattern of sexual preference (p \ 0.05), and reduced T plasma level Introduction (p \ 0.05) were observed for adult male rats exposed pre- natally to T.
    [Show full text]
  • California Proposition 65 (Prop65)
    20 NOVEMBER 2018 To Whom It May Concern: Certificate of Compliance California Proposition 65 California’s Proposition 65 entitles California consumers to special warnings for products that contain chemicals known to the state of California to cause cancer and birth defects or other reproductive harm if those products expose consumers to such chemicals above certain threshold levels. This is to certify that Alliance Memory comply with Safe Drinking Water and Toxic Enforcement Act of 1986, commonly known as California Proposition 65, that are ‘known to the state to cause cancer or reproductive toxicity’ as of December 29, 2017, by following the labelling guidelines set out therein. Alliance Memory labelling system clearly states a ‘Prop65 warning’ as and when necessary, on product packaging that is destined for the state of California, USA. This document certifies that to the best of our current knowledge and belief and under normal usage, Alliance Memory’s IC products are in compliance with California Proposition 65 – The Safe Drinking Water and Toxic Enforcement Act, 1986) and do not contain chemical elements of those listed within the California Proposition 65 chemical listing as shown below. Signature : Date: 20 November 2018 Name : Kim Bagby Title : Director QRA Department/Alliance Memory California Proposition 65 list of chemicals. The following is a list of chemicals published as a requirement of Safe Drinking Water and Toxic Enforcement Act of 1986, commonly known as California Proposition 65, that are ‘known to the state to cause
    [Show full text]
  • Health Effects Support Document for 1,1-Dichloro-2,2- Bis(P-Chlorophenyl)Ethylene (DDE)
    Health Effects Support Document for 1,1-Dichloro-2,2- bis(p-chlorophenyl)ethylene (DDE) Health Effects Support Document for 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) U.S. Environmental Protection Agency Office of Water (4304T) Health and Ecological Criteria Division Washington, DC 20460 www.epa.gov/safewater/ccl/pdf/DDE.pdf EPA Document Number EPA-822-R-08-003 January, 2008 Printed on Recycled Paper DDE — January, 2008 iv FOREWORD The Safe Drinking Water Act (SDWA), as amended in 1996, requires the Administrator of the Environmental Protection Agency (EPA) to establish a list of contaminants to aid the Agency in regulatory priority setting for the drinking water program. In addition, the SDWA requires EPA to make regulatory determinations for no fewer than five contaminants by August 2001 and every five years thereafter. The criteria used to determine whether or not to regulate a chemical on the Contaminant Candidate List (CCL) are the following: • The contaminant may have an adverse effect on the health of persons. • The contaminant is known to occur or there is a substantial likelihood that the contaminant will occur in public water systems with a frequency and at levels of public health concern. • In the sole judgment of the Administrator, regulation of such contaminant presents a meaningful opportunity for health risk reduction for persons served by public water systems. The Agency’s findings for all three criteria are used in making a determination to regulate a contaminant. The Agency may determine that there is no need for regulation when a contaminant fails to meet one of the criteria.
    [Show full text]
  • Residue Dynamics and Risk Assessment of Prochloraz and Its Metabolite 2,4,6-Trichlorophenol in Apple
    Article Residue Dynamics and Risk Assessment of Prochloraz and Its Metabolite 2,4,6-Trichlorophenol in Apple Qingkui Fang 1, Gengyou Yao 2, Yanhong Shi 2, Chenchun Ding 1, Yi Wang 2, Xiangwei Wu 2, Rimao Hua 2 and Haiqun Cao 1,* 1 School of Plant Protection, Provincial Key Laboratory for Agri-Food Safety, Anhui Agricultural University, Hefei 230036, China; [email protected] (Q.F.); [email protected] (C.D.) 2 School of Resource & Environment, Provincial Key Laboratory for Agri-Food Safety, Anhui Agricultural University, Hefei 230036, China; [email protected] (G.Y.); [email protected] (Y.S.); [email protected] (Y.W.); [email protected] (X.W.); [email protected] (R.H.) * Correspondence: [email protected] Received: 22 September 2017; Accepted: 19 October 2017; Published: 20 October 2017 Abstract: The residue dynamics and risk assessment of prochloraz and its metabolite 2,4,6- trichlorophenol (2,4,6-TCP) in apple under different treatment concentrations were investigated using a GC-ECD method. The derivatization percent of prochloraz to 2,4,6-TCP was stable and complete. The recoveries of prochloraz and 2,4,6-TCP were 82.9%–114.4%, and the coefficients of variation (CV) were 0.7%–8.6% for the whole fruit, apple pulp, and apple peel samples. Under the application of 2 °C 2.0 g/L, 2 °C 1.0 g/L, 20 °C 2.0 g/L, and 20 °C 1.0 g/L treatment, the half-life for the degradation of prochloraz was 57.8–86.6 d in the whole fruit and apple peel, and the prochloraz concentration in the apple pulp increased gradually until a peak (0.72 mg·kg−1) was reached.
    [Show full text]
  • A Cell-Free Testing Platform to Screen Chemicals of Potential Neurotoxic Concern Across Twenty Vertebrate Species
    Environmental Toxicology and Chemistry, Vol. 36, No. 11, pp. 3081–3090, 2017 # 2017 SETAC Printed in the USA A CELL-FREE TESTING PLATFORM TO SCREEN CHEMICALS OF POTENTIAL NEUROTOXIC CONCERN ACROSS TWENTY VERTEBRATE SPECIES a,b a,b a,c,d a a,e ADELINE ARINI, KRITTIKA MITTAL, PETER DORNBOS, JESSICA HEAD, JENNIFER RUTKIEWICZ, a,b, and NILADRI BASU * aDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, Michigan, USA bFaculty of Agricultural and Environmental Sciences, McGill University, Montreal, Quebec, Canada cDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan, USA dInstitute for Integrative Toxicology, Michigan State University, East Lansing, Michigan, USA eToxServices, Ann Arbor, Michigan, USA (Submitted 8 February 2017; Returned for Revision 9 March 2017; Accepted 5 June 2017) Abstract: There is global demand for new in vitro testing tools for ecological risk assessment. The objective of the present study was to apply a set of cell-free neurochemical assays to screen many chemicals across many species in a relatively high-throughput manner. The platform assessed 7 receptors and enzymes that mediate neurotransmission of g-aminobutyric acid, dopamine, glutamate, and acetylcholine. Each assay was optimized to work across 20 vertebrate species (5 fish, 5 birds, 7 mammalian wildlife, 3 biomedical species including humans). We tested the screening assay platform against 80 chemicals (23 pharmaceuticals and personal care products, 20 metal[loid]s, 22 polycyclic aromatic hydrocarbons and halogenated organic compounds, 15 pesticides). In total, 10 800 species–chemical–assay combinations were tested, and significant differences were found in 4041 cases. All 7 assays were significantly affected by at least one chemical in each species tested.
    [Show full text]